Abeje Yordanos Esubalew, Wieske Lianne H E, Poongavanam Vasanthanathan, Maassen Stefanie, Atilaw Yoseph, Cromm Philipp, Lehmann Lutz, Erdelyi Mate, Meibom Daniel, Kihlberg Jan
Department of Chemistry─BMC, Uppsala University, Box 576, 75123 Uppsala, Sweden.
Bayer AG, Drug Discovery Sciences, 42113 Wuppertal, Germany.
J Med Chem. 2025 Jan 9;68(1):638-657. doi: 10.1021/acs.jmedchem.4c02492. Epub 2024 Dec 18.
The discovery of cell permeable and orally bioavailable von Hippel-Lindau (VHL) proteolysis targeting chimeras (PROTACs) is challenging as their structures locates them at, or beyond, the outer limits of oral druggable space. We have designed a set of nine VHL PROTACs and found that the linker had a profound impact on passive cell permeability. Determination of the solution ensembles in a nonpolar solvent revealed that high permeability was correlated to the ability of the PROTACs to adopt folded conformations that have a low solvent accessible 3D polar surface area. Our results suggest that the design of cell permeable VHL PROTACs could focus on linkers that facilitate shielding of polar surface area in the VHL ligand in a nonpolar but not in a polar environment. In addition, we found that not only intramolecular hydrogen bonds, but also NH-π and π-π interactions contribute to the stabilization of low-polarity conformations, and thereby to high cell permeability.
发现具有细胞渗透性和口服生物利用度的靶向希佩尔-林道(VHL)蛋白水解靶向嵌合体(PROTAC)具有挑战性,因为它们的结构使其处于口服可药用空间的外部界限或超出该界限。我们设计了一组九个VHL PROTAC,并发现连接子对被动细胞渗透性有深远影响。在非极性溶剂中测定溶液集合体表明,高渗透性与PROTAC采取折叠构象的能力相关,这些构象具有低溶剂可及的三维极性表面积。我们的结果表明,设计具有细胞渗透性的VHL PROTAC可以专注于在非极性而非极性环境中促进VHL配体极性表面积屏蔽的连接子。此外,我们发现不仅分子内氢键,而且NH-π和π-π相互作用也有助于低极性构象的稳定,从而有助于高细胞渗透性。